ACM
TENX icon

ADAR1 Capital Management’s Tenax Therapeutics TENX Stock Holding History

ADAR1 Capital Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.41M Buy
213,462
+149,789
+235% +$2.03M 0.2% 100
2025
Q4 		$776K Buy
63,673
+10,245
+19% +$89.1K 0.06% 154
2025
Q3 		$407K Sell
53,428
-102,129
-66% -$624K 0.04% 149
2025
Q2 		$896K Buy
155,557
+86,816
+126% +$502K 0.14% 91
2025
Q1 		$450K Buy
68,741
+34,048
+98% +$218K 0.08% 112
2024
Q4 		$215K Sell
34,693
-27,730
-44% -$135K 0.04% 154
2024
Q3 		$216K Buy
+62,423
New +$226K 0.04% 158

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ADAR1 Capital Management's TENX Position: Q1 2026 in Review

ADAR1 Capital Management increased its Tenax Therapeutics (TENX) stake by 235% in Q1 2026, buying an estimated $2.03M and bringing the position to 213,462 shares worth $3.41M. The position accounts for 0.2% of the portfolio, ranked #100.

ADAR1 Capital Management first reported a position in TENX in Q3 2024 and has held it in 7 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • ADAR1 Capital Management held 213,462 shares of Tenax Therapeutics worth $3.41M as of Q1 2026.
  • ADAR1 Capital Management bought 149,789 Tenax Therapeutics shares in Q1 2026, an estimated $2.03M.
  • Tenax Therapeutics made up 0.2% of ADAR1 Capital Management's portfolio in Q1 2026, its #100 holding.
  • ADAR1 Capital Management first reported a position in Tenax Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.